CHYM heads into the week with an unusual split: shorts have quietly added exposure over the past month, yet the Street just opened with a fresh bullish initiation from a major bank.
Barclays kicked off coverage this morning with an Overweight rating, the most recent in a string of constructive analyst actions since Chime went public. Wells Fargo lifted its target to $28 from $25 after the last earnings print, and Canaccord has maintained a $40 Buy. The consensus sits at Buy with a mean target of $30.26 — roughly 43% above the current price of $21.12. Bulls point to platform revenue growing at an average 90% clip over the past four quarters, ARPAM of $245 up 6% year-on-year, and a neobank model targeting underbanked consumers that looks structurally different from traditional payments names. Bears counter with a familiar set of concerns: a macro-sensitive credit book, competitive pressure across the fintech landscape, and ongoing questions about whether member acquisition can stay efficient at scale. UBS and Rothschild sit on the sidelines with Neutral ratings, the two meaningful holdouts in an otherwise positive consensus.
The short side tells a more nuanced story. Short interest has climbed 44% over the past month to 4.6% of the free float — real movement, but not an extreme level. What makes it notable is the pace: shorts were closer to 3.2% of float in late May and have been building steadily since early June. The ORTEX short score has ticked up over the same period, sitting at 45.8 on Tuesday after touching a recent high of 48.9 last week, before easing back. That said, the lending market is far from stressed. Availability is loose at 911% — meaning there are roughly nine shares available to borrow for every one already lent out — and cost to borrow has collapsed over the past week to just 0.23%, down from 0.55% at the end of June. Short sellers are adding exposure, but they are doing so cheaply and with ample room to manoeuvre.
Options positioning offers no strong directional read at this point. The put/call ratio is running at 0.45, essentially in line with its 20-day average of 0.43 and sitting well inside its 52-week range of 0.25–0.52. There is no outsized hedging demand and no aggressive call-buying surge — options traders are largely neutral heading into the next print.
The ownership picture is worth a glance given the recent insider activity. A cluster of executive sales hit on May 15, with the CEO, CFO, President, General Counsel, and Chief Accounting Officer all selling on the same day at $17.88. The General Counsel followed up with two smaller sales in June. The stock now trades at $21.12, up 18% from those May execution prices, which partly explains the timing as post-lockup or planned selling. Tiger Global trimmed its position by 3.1 million shares as of March 31, while Vanguard disclosed a fresh initial position in the same quarter. The top-five holders — DST Global, CrossLink Capital, General Atlantic, Menlo Ventures, and co-founder Ryan King — remain large and broadly steady.
Earnings history is worth flagging ahead of the August 6 release. The two confirmed post-IPO prints both produced sharp one-day declines: -8.2% after the June 2 report and -8.6% after the May 6 release. The five-day picture was worse, with the stock drifting a further 3-8% lower in the week following each print. That pattern — a relatively small initial reaction that compounds into a larger move — is worth tracking given that short interest was lower at both prior events than it is today. The August print is therefore less a question of whether Chime can sustain its revenue growth rate and more a question of whether 30%+ appreciation since the IPO price has already absorbed the good news.
TOST gained 5.1% on the week while PAY surged 18.7%, making CHYM's own 3.1% weekly gain look modest in comparison. With Barclays now on board and the next earnings catalyst five weeks away, how short interest evolves into that August print — and whether the borrow market stays this relaxed — is the key dynamic to monitor.
See the live data behind this article on ORTEX.
Open CHYM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
